ROIV Roivant Sciences Ltd.
Healthcare$29.50+0.00%OpenMarket Cap: $21.22B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$36.17
Target (Median)
$37.00
Target Range
$30.00 - $42.00
Upside from current price: 22.6%
Rating Distribution
2 Strong Buy10 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-21 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-21 | TD Cowen | maintain | Buy | Buy |
| 2026-05-21 | Citigroup | maintain | Buy | Buy |
| 2026-04-16 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-03-04 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-10 | Citigroup | maintain | Buy | Buy |
| 2026-02-09 | Guggenheim | maintain | Buy | Buy |
| 2025-12-15 | Goldman Sachs | maintain | Buy | Buy |
| 2025-12-15 | Leerink Partners | maintain | Outperform | Outperform |
| 2025-12-12 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Wed Mar 31 | $-1.16 | $79.9M | 4 |
| Fri Mar 31 | $-1.01 | $578.1M | 4 |
| Sat Mar 31 | $0.17 | $1.83B | 6 |
| Sun Mar 31 | $1.22 | $3.17B | 2 |